Navigation Links
Vanda Pharmaceuticals Reports First Quarter 2009 Results
Date:4/29/2009

kes or that are made on its behalf. The information in this release is provided only as of the date of this release, and Vanda undertakes no obligation, and specifically declines any obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

                           VANDA PHARMACEUTICALS INC.
                        (A Development Stage Enterprise)

            CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

                                             Three Months Ended
                                             ------------------
                                        March 31,          March 31,
                                           2009               2008
                                           ----               ----

    Revenue                                    $-                  $-
                                            -----               -----
    Operating expenses:
      Research and development          2,333,344          11,102,665
      General and administrative        4,224,031           8,959,214
                                        ---------           ---------
         Total operating expenses       6,557,375          20,061,879
                                        ---------          ----------

    Loss from operations               (6,557,375)        (20,061,879)

    Interest income                        53,387             865,750
                                           ------             -------
         Total other income, net           53,387             865,750
                                           ------             -------

    Net loss                          $(6,503,988)       $(19,196,129)
                                      ===========        ============

    Basic and diluted net loss per
     share attributable to
     common stockholders
'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results
2. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
3. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
4. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
5. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
6. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
7. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
8. Onyx Pharmaceuticals Announces First Quarter 2009 Financial Results Teleconference and Webcast
9. Transcept Pharmaceuticals to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
10. Inimex Pharmaceuticals begins First Clinical Study of an Innate Defense Regulator
11. Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... A paper published today, " Financing ... in Science Translational Medicine, demonstrates the ... the risk associated with investing in the treatment ... of funding for developing so-called "orphan" drugs. ... between scientists at the National Center for Advancing ...
(Date:2/27/2015)... , Feb. 27, 2015 Bionomics Limited ... the DisrupTOR-1 trial of BNC105 in patients with metastatic ... Orlando, Florida . The data will ... the City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and IL-8 ...
(Date:2/27/2015)...  Steep Hill, the industry leader in cannabis testing ... open a full service medical cannabis quality assurance laboratory ... advanced scientific tools and methodology to the state, for ... currently the only laboratory licensed by the New Mexico ... in order to meet the recently adopted regulatory requirements ...
(Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading ... Kate Black as Privacy Officer and Corporate Counsel. ... state privacy laws as well as health care regulations. ... she will be responsible for reviewing, updating and enhancing ... the U.S. and abroad. She joined the company January ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 223andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2
... 30 Informex ( http://www.informex.com ), the ... chemistry for a broad range of applications, today announced ... on November 9, 2010 in Milwaukee, Wisconsin. The Pharma ... to act as a knowledge conduit for the chemical ...
... Health 2.0 announces six winners of the 2010 Health ... Health 2.0 Developer Challenge session at the Health 2.0 ... Roll Please! Accelerating Wireless Health ... West Wireless Health Institute, chose team Videntity . ...
... of Microplasmin -- LEUVEN, Belgium, September 30, 2010 ... ... ... // Results are keyed by longUrl, so we need to grab the first one. for (var r ...
Cached Biology Technology:Inaugural Pharma Exchange Conference Produced by Informex to Draw Together Milwaukee, Wisconsin Chemical Industry 2Inaugural Pharma Exchange Conference Produced by Informex to Draw Together Milwaukee, Wisconsin Chemical Industry 3Health 2.0 Reveals the Winners of the 2010 Developer Challenge 2Health 2.0 Reveals the Winners of the 2010 Developer Challenge 3ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin 2ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin 3ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin 4ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin 5ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin 6ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin 7ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin 8
(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... website ( http://www.nxt-id.com/ ) as part of its 2015 ... The Company launched its new consumer website for Wocketwallet.com ... , CEO of NXT-ID said, "Our new corporate website ...
(Date:2/5/2015)... 28, 2015 New Market Research ... Segment Forecasts To 2020 has Been Added to GrandViewReseach.com ... is expected to reach USD 5.10 billion by 2020, ... Inc. IR cameras help identify the site of tissue ... witness surging demand in medical imaging applications. They have ...
(Date:2/5/2015)... 28, 2015 Research and Markets ... the "Global Biometrics Market (2014-2020): Market Forecast ... report to their offering. , ... is anticipated to overtake ... increasing government spending towards IT security, government biometric ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3
... When cells go about the business of dividing, they can ... the right signals to resume multiplying. Either way, cells go ... that drives the development of embryos, the renewal of hair, ... a single transcription factor called GABP, according to new research ...
... cats--have brains with a somewhat mysterious feature: The outermost ... of these folds is one of the big open ... by MIT, Massachusetts General Hospital and Harvard Medical School ... studies by helping researchers “see?how those folds develop and ...
... of the horse genome sequence has been deposited in ... biomedical and veterinary researchers around the globe, leaders of ... The $15 million effort to sequence the approximately 2.7 ... horse (Equus caballus) was funded by the National Human ...
Cached Biology News:Brown cancer biologists identify major player in cell growth 2MIT model helps researchers 'see' brain development 2Horse genome assembled 2Horse genome assembled 3
SP6 RNA Polymerase, 50 l, 20 U/l ,Cap Scribe Buffer, 100 l, 5x conc....
Miniature FRENCH Pressure Cell with 3.7ml capacity; pressure up to 20,000 psi....
...
... Nepheloskan Ascent is the first ... in microplates. Nepheloskan measures light ... technique for particle quantification. This ... testing in drug discovery, immunoprecipitation, ...
Biology Products: